Testosterone and the brain

Journal of Men's Health and Gender

Volumn 4, Issue 3, 2007, Pages 344-351

  Gooren, Louis ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alzheimer's disease; Androgen deprivation treatment; Cognitive functions; Depression; Sex difference; Testosterone

Indexed keywords

ANABOLIC AGENT; ANDROGEN; ANTIANDROGEN; CYPROTERONE ACETATE; ESTROGEN; GONADORELIN; TESTOSTERONE;

AGGRESSION; AGING; ALZHEIMER DISEASE; ARTICLE; COGNITION; DEPRESSION; DEPTH PERCEPTION; DISEASE ASSOCIATION; DRUG EFFICACY; ERECTILE DYSFUNCTION; FATIGUE; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE DEFICIENCY; HUMAN; HYPOGONADISM; LIBIDO; MENTAL DISEASE; MENTAL FUNCTION; MOOD DISORDER; PRIORITY JOURNAL; PROSTATE CANCER; PSYCHOMETRY; QUALITY OF LIFE; SEX DIFFERENCE; SIDE EFFECT; TREATMENT OUTCOME;

EID: 34548282093     PISSN: 15718913     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmhg.2007.06.001     Document Type: Article

References (66)

1. Kruijver F.P., Fernandez-Guasti A., Fodor M., Kraan E.M., and Swaab D.F. Sex differences in androgen receptors of the human mamillary bodies are related to endocrine status rather than to sexual orientation or transsexuality. J Clin Endocrinol Metab 86 (2001) 818-827
2. Kruijver F.P., Balesar R., Espila A.M., Unmehopa U.A., and Swaab D.F. Estrogen-receptor-beta distribution in the human hypothalamus: similarities and differences with ER alpha distribution. J Comp Neurol 466 (2003) 251-277
3. Toran-Allerand C.D. Minireview: A plethora of estrogen receptors in the brain: where will it end?. Endocrinology 145 (2004) 1069-1074
4. Puy L., MacLusky N.J., Becker L., Karsan N., Trachtenberg J., and Brown T.J. Immunocytochemical detection of androgen receptor in human temporal cortex characterization and application of polyclonal androgen receptor antibodies in frozen and paraffin-embedded tissues. J Steroid Biochem Mol Biol 55 (1995) 197-209
5. Stoffel-Wagner B. Neurosteroid biosynthesis in the human brain and its clinical implications. Ann N Y Acad Sci 1007 (2003) 64-78
6. Poletti A., and Martini L. Androgen-activating enzymes in the central nervous system. J Steroid Biochem Mol Biol 69 (1999) 117-122
7. Altman J. Gonadal hormones humour the brain. Neuroendocrinology 79 (2004) 287-295
8. Beauchet O. Testosterone and cognitive function: current clinical evidence of a relationship. Eur J Endocrinol 155 (2006) 773-781
9. Zitzmann M. Testosterone and the brain. Aging Male 9 (2006) 195-199
10. Janowsky J.S. The role of androgens in cognition and brain aging in men. Neuroscience 138 (2006) 1015-1020
11. Van Goozen S.H., Cohen-Kettenis P.T., Gooren L.J., Frijda N.H., and Van de Poll N.E. Gender differences in behaviour: activating effects of cross-sex hormones. Psychoneuroendocrinology 20 (1995) 343-363
12. Cherrier M.M. Androgens and cognitive function. J Endocrinol Invest 28 (2005) 65-75
13. Barrett-Connor E., Goodman-Gruen D., and Patay B. Endogenous sex hormones and cognitive function in older men. J Clin Endocrinol Metab 84 (1999) 3681-3685
14. Gouchie C., and Kimura D. The relationship between testosterone levels and cognitive ability patterns. Psychoneuroendocrinology 16 (1991) 323-334
15. Moffat S.D., Zonderman A.B., Metter E.J., Blackman M.R., Harman S.M., and Resnick S.M. Longitudinal assessment of serum free testosterone concentration predicts memory performance and cognitive status in elderly men. J Clin Endocrinol Metab 87 (2002) 5001-5007
16. Morley J.E., Kaiser F., Raum W.J., Perry III H.M., Flood J.F., et al. Potentially predictive and manipulable blood serum correlates of aging in the healthy human male: progressive decreases in bioavailable testosterone, dehydroepiandrosterone sulfate, and the ratio of insulin-like growth factor 1 to growth hormone. Proc Natl Acad Sci USA 94 (1997) 7537-7542
17. Silverman I., Kastuk D., Choi J., and Phillips K. Testosterone levels and spatial ability in men. Psychoneuroendocrinology 24 (1999) 813-822
18. Muller M., Aleman A., Grobbee D.E., de Haan E.H., and van der Schouw Y.T. Endogenous sex hormone levels and cognitive function in aging men: is there an optimal level?. Neurology 64 (2005) 866-871
19. Moffat S.D., and Hampson E. A curvilinear relationship between testosterone and spatial cognition in humans: possible influence of hand preference. Psychoneuroendocrinology 21 (1996) 323-337
20. Yaffe K., Lui L.Y., Zmuda J., and Cauley J. Sex hormones and cognitive function in older men. J Am Geriatr Soc 50 (2002) 707-712
21. Yaffe K., Barnes D., Lindquist K., Cauley J., Simonsick E.M., Penninx B., et al. Endogenous sex hormone levels and risk of cognitive decline in an older biracial cohort. Neurobiology of aging 28 (2007) 171-178
22. Yaffe K. Metabolic syndrome and cognitive decline. Current Alzheimer Research 4 (2007) 123-126
23. Fonda S.J., Bertrand R., O'Donnell A., Longcope C., and McKinlay J.B. Age, hormones, and cognitive functioning among middle-aged and elderly men: cross-sectional evidence from the Massachusetts Male Aging Study. J Gerontol A Biol Sci Med Sci 60 (2005) 385-390
24. Wang C., Swerdloff R.S., Iranmanesh A., Dobs A., Snyder P.J., Cunningham G., et al. Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. J Clin Endocrinol Metab 85 (2000) 2839-2853
25. Bagatell C.J., Heiman J.R., Matsumoto A.M., Rivier J.E., and Bremner W.J. Metabolic and behavioral effects of high-dose, exogenous testosterone in healthy men. J Clin Endocrinol Metab 79 (1994) 561-567
26. O'Connor D.B., Archer J., and Wu F.C. Effects of testosterone on mood, aggression, and sexual behavior in young men: a double-blind, placebo-controlled, cross-over study. J Clin Endocrinol Metab 89 (2004) 2837-2845
27. Pope Jr. H.G., Kouri E.M., Powell K.F., Campbell C., and Katz D.L. Anabolic-androgenic steroid use among 133 prisoners. Compr Psychiatry 37 (1996) 322-327
28. Cherrier M.M., Matsumoto A.M., Amory J.K., Asthana S., Bremner W., Peskind E.R., et al. Testosterone improves spatial memory in men with Alzheimer disease and mild cognitive impairment. Neurology 64 (2005) 2063-2068
29. Cherrier M.M., Matsumoto A.M., Amory J.K., Ahmed S., Bremner W., Peskind E.R., et al. The role of aromatization in testosterone supplementation: effects on cognition in older men. Neurology 64 (2005) 290-296
30. Kenny A.M., Fabregas G., Song C., Biskup B., and Bellantonio S. Effects of testosterone on behavior, depression, and cognitive function in older men with mild cognitive loss. J Gerontol A Biol Sci Med Sci 59 (2004) 75-78
31. Sih R., Morley J.E., Kaiser F.E., Perry III H.M., Patrick P., and Ross C. Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. J Clin Endocrinol Metab 82 (1997) 1661-1667
32. McEwen B.S. Invited review: Estrogens effects on the brain: multiple sites and molecular mechanisms. J Appl Physiol 91 (2001) 2785-2801
33. Schumacher M. Rapid membrane effects of steroid hormones: an emerging concept in neuroendocrinology. Trends Neurosci 13 (1990) 359-362
34. Carlson L.E., and Sherwin B.B. Higher levels of plasma estradiol and testosterone in healthy elderly men compared with age-matched women may protect aspects of explicit memory. Menopause 7 (2000) 168-177
35. Zitzmann M., Faber S., and Nieschlag E. Association of specific symptoms and metabolic risks with serum testosterone in older men. J Clin Endocrinol Metab 91 (2006) 4335-4343
36. Wang C., Cunningham G., Dobs A., Iranmanesh A., Matsumoto A.M., Snyder P.J., et al. Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. J Clin Endocrinol Metab 89 (2004) 2085-2098
37. Loizides E., Swierzewski M.J., O'Neill C., Griesser J., and Smith T. Early response time in sexual activity and mood following testosterone gel replacement in hypogonadal males from the Testim(R) START Study. Rev Urol 6 Suppl 6 (2004) S16-S21
38. McNicholas T.A., Dean J.D., Mulder H., Carnegie C., and Jones N.A. A novel testosterone gel formulation normalizes androgen levels in hypogonadal men, with improvements in body composition and sexual function. BJU Int 91 (2003) 69-74
39. Barrett-Connor E., Von Muhlen D.G., and Kritz-Silverstein D. Bioavailable testosterone and depressed mood in older men: the Rancho Bernardo Study. J Clin Endocrinol Metab 84 (1999) 573-577
40. Shores M.M., Moceri V.M., Gruenewald D.A., Brodkin K.I., Matsumoto A.M., and Kivlahan D.R. Low testosterone is associated with decreased function and increased mortality risk: a preliminary study of men in a geriatric rehabilitation unit. J Am Geriatr Soc 52 (2004) 2077-2081
41. Araujo A.B., Durante R., Feldman H.A., Goldstein I., and McKinlay J.B. The relationship between depressive symptoms and male erectile dysfunction: cross-sectional results from the Massachusetts Male Aging Study. Psychosom Med 60 (1998) 458-465
42. Mazur A. Biosocial models of deviant behavior among male army veterans. Biol Psychol 41 (1995) 271-293
43. Seidman S.N., Araujo A.B., Roose S.P., and McKinlay J.B. Testosterone level, androgen receptor polymorphism, and depressive symptoms in middle-aged men. Biol Psychiatry 50 (2001) 371-376
44. Harkonen K., Huhtaniemi I., Makinen J., Hubler D., Irjala K., Koskenvuo M., et al. The polymorphic androgen receptor gene CAG repeat, pituitary-testicular function and andropausal symptoms in ageing men. Int J Androl 26 (2003) 187-194
45. Perry P.J., Yates W.R., Williams R.D., Andersen A.E., MacIndoe J.H., Lund B.C., et al. Testosterone therapy in late-life major depression in males. J Clin Psychiatry 63 (2002) 1096-1101
46. Pope Jr. H.G., Cohane G.H., Kanayama G., Siegel A.J., and Hudson J.I. Testosterone gel supplementation for men with refractory depression: a randomized, placebo-controlled trial. Am J Psychiatry 160 (2003) 105-111
47. Grinspoon S., Corcoran C., Stanley T., Baaj A., Basgoz N., and Klibanski A. Effects of hypogonadism and testosterone administration on depression indices in HIV-infected men. J Clin Endocrinol Metab 85 (2000) 60-65
48. Seidman S.N., Spatz E., Rizzo C., and Roose S.P. Testosterone replacement therapy for hypogonadal men with major depressive disorder: a randomized, placebo-controlled clinical trial. J Clin Psychiatry 62 (2001) 406-412
49. Seidman S.N. Normative hypogonadism and depression: does 'andropause' exist?. Int J Impot Res 18 (2006) 414-422
50. Paoletti A.M., Congia S., Lello S., Tedde D., Orru M., Pistis M., et al. Low androgenization index in elderly women and elderly men with Alzheimer's disease. Neurology 62 (2004) 301-303
51. Okun M.S., DeLong M.R., Hanfelt J., Gearing M., and Levey A. Plasma testosterone levels in Alzheimer and Parkinson diseases. Neurology 62 (2004) 411-413
52. Gillett M.J., Martins R.N., Clarnette R.M., Chubb S.A., Bruce D.G., and Yeap B.B. Relationship between testosterone, sex hormone binding globulin and plasma amyloid beta peptide 40 in older men with subjective memory loss or dementia. J Alzheimers Dis 5 (2003) 267-269
53. Moffat S.D., Zonderman A.B., Metter E.J., Kawas C., Blackman M.R., Harman S.M., et al. Free testosterone and risk for Alzheimer disease in older men. Neurology 62 (2004) 188-193
54. Geerlings M.I., Strozyk D., Masaki K., Remaley A.T., Petrovitch H., Ross G.W., et al. Endogenous sex hormones, cognitive decline, and future dementia in old men. Ann Neurol 60 (2006) 346-355
55. Burkhardt M.S., Foster J.K., Clarnette R.M., Chubb S.A., Bruce D.G., Drummond P.D., et al. Interaction between testosterone and apolipoprotein E epsilon4 status on cognition in healthy older men. J Clin Endocrinol Metab 91 (2006) 1168-1172
56. Lu P.H., Masterman D.A., Mulnard R., Cotman C., Miller B., Yaffe K., et al. Effects of testosterone on cognition and mood in male patients with mild Alzheimer disease and healthy elderly men. Arch Neurol 63 (2006) 177-185
57. Tan R.S., and Pu S.J. A pilot study on the effects of testosterone in hypogonadal aging male patients with Alzheimer's disease. Aging Male 6 (2003) 13-17
58. Potosky A.L., Reeve B.B., Clegg L.X., Hoffman R.M., Stephenson R.A., Albertsen P.C., et al. Quality of life following localized prostate cancer treated initially with androgen deprivation therapy or no therapy. J Natl Cancer Inst 94 (2002) 430-437
59. Potosky A.L., Knopf K., Clegg L.X., Albertsen P.C., Stanford J.L., Hamilton A.S., et al. Quality-of-life outcomes after primary androgen deprivation therapy: results from the Prostate Cancer Outcomes Study. J Clin Oncol 19 (2001) 3750-3757
60. Lubeck D.P., Grossfeld G.D., and Carroll P.R. The effect of androgen deprivation therapy on health-related quality of life in men with prostate cancer. Urology 58 (2001) 94-100
61. Dacal K., Sereika S.M., and Greenspan S.L. Quality of life in prostate cancer patients taking androgen deprivation therapy. J Am Geriatr Soc 54 (2006) 85-90
62. Basaria S., Lieb II J., Tang A.M., DeWeese T., Carducci M., Eisenberger M., et al. Long-term effects of androgen deprivation therapy in prostate cancer patients. Clin Endocrinol (Oxf) 56 (2002) 779-786
63. Pirl W.F., Siegel G.I., Goode M.J., and Smith M.R. Depression in men receiving androgen deprivation therapy for prostate cancer: a pilot study. Psycho-oncology 11 (2002) 518-523
64. Stone P., Hardy J., Huddart R., A'Hern R., and Richards M. Fatigue in patients with prostate cancer receiving hormone therapy. Eur J Cancer 36 (2000) 1134-1141
65. Couper J.W., Bloch S., Love A., Duchesne G., Macvean M., and Kissane D.W. The psychosocial impact of prostate cancer on patients and their partners. Med J Aust 185 (2006) 428-432
66. Higano C. Androgen deprivation therapy: monitoring and managing the complications. Hematol Oncol Clin North Am 20 (2006) 909-923